Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mai Kosaka"'
Autor:
Kayoko Kimura, Hiroko Iwata, Emi Mori, Kunie Maehara, Fusae Toyama, Asana Kakehashi, Marika Seki, Sayaka Abe, Mai Kosaka
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction The objective of this scoping review is to map the literature describing preventive interventions for paternal perinatal depression. Depression is a common mental disorder experienced by fathers as well as mothers around childbirth. Peri
Externí odkaz:
https://doaj.org/article/3f2d68db5df641928d1fbb5833e7879a
Autor:
Hiroko Iwata, Emi Mori, Kunie Maehara, Kayoko Kimura, Fusae Toyama, Asana Kakehashi, Marika Seki, Sayaka Abe, Mai Kosaka
Publikováno v:
BMJ Open. 13:e065126
IntroductionThe objective of this scoping review is to map the literature describing preventive interventions for paternal perinatal depression. Depression is a common mental disorder experienced by fathers as well as mothers around childbirth. Perin
Autor:
Shinji Iwasaki, Atsutoshi Furuta, Mai Kosaka, Miyuki Funami, Sayaka Nakagawa, Noriyasu Sano, Yohei Kosugi, Andy Z. X. Zhu, Hideki Hirabayashi, Nobuyuki Amano
Publikováno v:
Xenobiotica. 49:1251-1259
1. This study evaluated the prediction accuracy of cytochrome P450 (CYP)-mediated drug-drug interaction (DDI) using minimal physiologically-based pharmacokinetic (PBPK) modelling incorporating the hepatic accumulation factor of an inhibitor (i.e. unb
Publikováno v:
Journal of Pharmaceutical Sciences. 106:2839-2846
In this article, we proposed a risk assessment strategy for CYP3A time-dependent inhibition (TDI) during drug discovery based on a thorough retrospective study of 13 reference drugs, some of which are known to have in vitro TDI potential but have unk
Publikováno v:
JBI evidence synthesis. 18(1)
Objective This systematic review aims to identify and synthesize available qualitative evidence related to the experiences of transition to motherhood during pregnancy in women who conceived through assisted reproductive technology (ART). Introductio
Autor:
Douglas R. Cary, Ryosuke Arai, Daisuke Morishita, Junpei Takeda, Shinobu Sasaki, Ryo Mizojiri, Sachio Shibata, Koichiro Fukuda, Misa Iwatani-Yoshihara, Mai Kosaka, Yohei Kosugi, Yoshihiko Satoh, Daisuke Nakata, Masahiro Kamaura, Kazuaki Takami, Yasuhiro Imaeda, Shigekazu Sasaki
Starting from our previous eIF4A3-selective inhibitor 1a, a novel series of (piperazine-1-carbonyl)pyridin-2(1H)-one derivatives was designed, synthesized, and evaluated for identification of orally bioavailable probe molecules. Compounds 1o and 1q s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648ce1d3f94549d028a6b107ac3f5ffa
https://europepmc.org/articles/PMC5642020/
https://europepmc.org/articles/PMC5642020/
Autor:
Mai Kosaka, Misa Iwatani-Yoshihara, Daisuke Morishita, Masahiro Kamaura, Shinobu Sasaki, Shigekazu Sasaki, Douglas R. Cary, Sachio Shibata, Ryo Mizojiri, Koichiro Fukuda, Yoshihiko Satoh, Ryosuke Arai, Yohei Kosugi, Kazuaki Takami, Daisuke Nakata, Yasuhiro Imaeda, Junpei Takeda
Publikováno v:
Cancer Research. 78:2793-2793
Eukaryotic initiation factor 4A3 (eIF4A3) is a member of the ATP-dependent RNA helicase protein family and controls RNA metabolism, including nonsense-mediated mRNA decay (NMD) and RNA localization, as a core component of the exon junction complex (E